# FDA Inspection 1162020 - Ann E. Hyslop Segeren, M.D. - February 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/ann-e-hyslop-segeren-md/10233f79-2e67-45a5-8350-ffc21ef53953
Source feed: FDA_Inspections

> FDA Inspection 1162020 for Ann E. Hyslop Segeren, M.D. on February 04, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162020
- Company Name: Ann E. Hyslop Segeren, M.D.
- Inspection Date: 2022-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/ann-e-hyslop-segeren-md/9ada43a4-84f0-4818-882f-5517e2bb82e3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c